Literature DB >> 22124170

Chronic kidney disease: Endogenous filtration markers--is it time to move beyond eGFR?

Andrew D Rule, Hisham Elsherbiny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22124170     DOI： 10.1038/nrneph.2011.193

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.

Authors:  Julia Lewis; Tom Greene; Lawrence Appel; Gabriel Contreras; Janice Douglas; Jim Lash; Robert Toto; Fredrick Van Lente; Xuelei Wang; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

2.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications.

Authors:  Chi-yuan Hsu; Kathleen Propert; Dawei Xie; Lee Hamm; Jiang He; Edgar Miller; Akinlolu Ojo; Michael Shlipak; Valerie Teal; Raymond Townsend; Matthew Weir; Jillian Wilson; Harold Feldman
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

3.  Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Authors:  Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2011-09-22       Impact factor: 8.860

4.  A randomized, controlled trial of early versus late initiation of dialysis.

Authors:  Bruce A Cooper; Pauline Branley; Liliana Bulfone; John F Collins; Jonathan C Craig; Margaret B Fraenkel; Anthony Harris; David W Johnson; Joan Kesselhut; Jing Jing Li; Grant Luxton; Andrew Pilmore; David J Tiller; David C Harris; Carol A Pollock
Journal:  N Engl J Med       Date:  2010-06-27       Impact factor: 91.245

5.  Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease.

Authors:  Xuelei Wang; Julia Lewis; Lawrence Appel; DeAnna Cheek; Gabriel Contreras; Marquetta Faulkner; Harold Feldman; Jennifer Gassman; Janice Lea; Joel Kopple; Mohammed Sika; Robert Toto; Tom Greene
Journal:  J Am Soc Nephrol       Date:  2006-09-20       Impact factor: 10.121

6.  Estimated GFR associates with cardiovascular risk factors independently of measured GFR.

Authors:  Ulla Dorte Mathisen; Toralf Melsom; Ole C Ingebretsen; Trond Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 10.121

7.  Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

Authors:  A S Levey; T Greene; M D Schluchter; P A Cleary; P E Teschan; R A Lorenz; M E Molitch; W E Mitch; C Siebert; P M Hall
Journal:  J Am Soc Nephrol       Date:  1993-11       Impact factor: 10.121

8.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

9.  Method of glomerular filtration rate estimation affects prediction of mortality risk.

Authors:  Brad C Astor; Andrew S Levey; Lesley A Stevens; Frederick Van Lente; Elizabeth Selvin; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

10.  Cystatin C as a risk factor for outcomes in chronic kidney disease.

Authors:  Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.